Your browser doesn't support javascript.
loading
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort.
Garcia Campelo, Maria Rosario; Zhou, Caicun; Ramalingam, Suresh S; Lin, Huamao M; Kim, Tae Min; Riely, Gregory J; Mekhail, Tarek; Nguyen, Danny; Goodman, Erin; Mehta, Minal; Popat, Sanjay; Jänne, Pasi A.
Afiliación
  • Garcia Campelo MR; Department of Medical Oncology, University Hospital Complex A Coruña, 15006 A Coruña, Spain.
  • Zhou C; Department of Oncology, Shanghai Pulmonary Hospital, Shanghai 200433, China.
  • Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
  • Lin HM; Takeda Development Center Americas, Inc., Lexington, MA 02421, USA.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Mekhail T; Advent Health Orlando, Orlando, FL 32803, USA.
  • Nguyen D; Pacific Shores Medical Group, Long Beach, CA 90813, USA.
  • Goodman E; Takeda Development Center Americas, Inc., Lexington, MA 02421, USA.
  • Mehta M; Takeda Development Center Americas, Inc., Lexington, MA 02421, USA.
  • Popat S; Lung Unit, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Jänne PA; The Institute of Cancer Research, University of London, London SM2 5NG, UK.
J Clin Med ; 12(1)2022 Dec 23.
Article en En | MEDLINE | ID: mdl-36614913
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: España